Federated Hermes’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.36M Buy
13,152
+2,431
+23% +$276K ﹤0.01% 1044
2025
Q4
$1.08M Sell
10,721
-45,759
-81% -$4.97M ﹤0.01% 1099
2025
Q3
$6.96M Sell
56,480
-404,166
-88% -$50.2M 0.01% 665
2025
Q2
$55.3M Buy
460,646
+120,845
+36% +$16.1M 0.1% 245
2025
Q1
$50M Buy
339,801
+47,751
+16% +$7.29M 0.11% 235
2024
Q4
$47.4M Buy
292,050
+155,383
+114% +$25.4M 0.1% 243
2024
Q3
$22.3M Buy
136,667
+70,857
+108% +$10.5M 0.05% 401
2024
Q2
$8.98M Buy
65,810
+7,916
+14% +$1.1M 0.02% 584
2024
Q1
$8.86M Buy
57,894
+30,198
+109% +$4.51M 0.02% 593
2023
Q4
$3.95M Buy
27,696
+22,952
+484% +$3.06M 0.01% 782
2023
Q3
$622K Buy
4,744
+670
+16% +$102K ﹤0.01% 1274
2023
Q2
$648K Sell
4,074
-1,422,461
-100% -$229M ﹤0.01% 1279
2023
Q1
$226M Sell
1,426,535
-806,921
-36% -$121M 0.57% 35
2022
Q4
$313M Buy
2,233,456
+72,133
+3% +$10.2M 0.87% 18
2022
Q3
$277M Buy
2,161,323
+215,425
+11% +$31.1M 0.81% 20
2022
Q2
$274M Buy
1,945,898
+901,040
+86% +$129M 0.75% 19
2022
Q1
$145M Buy
1,044,858
+1,043,407
+71,910% +$160M 0.33% 72
2021
Q4
$253K Sell
1,451
-33
-2% -$5.5K ﹤0.01% 1608
2021
Q3
$246K Sell
1,484
-149
-9% -$25.7K ﹤0.01% 1632
2021
Q2
$294K Sell
1,633
-17,807
-92% -$3.25M ﹤0.01% 1615
2021
Q1
$3.75M Sell
19,440
-60,222
-76% -$11.6M 0.01% 926
2020
Q4
$16.1M Sell
79,662
-99,157
-55% -$20.5M 0.03% 523
2020
Q3
$37.6M Sell
178,819
-11,310
-6% -$2.52M 0.09% 263
2020
Q2
$41.7M Buy
190,129
+30,789
+19% +$6.15M 0.1% 224
2020
Q1
$27.6M Buy
159,340
+157,739
+9,853% +$26.1M 0.08% 268
2019
Q4
$246K Sell
1,601
-151
-9% -$22.6K ﹤0.01% 1570
2019
Q3
$266K Sell
1,752
-22,017
-93% -$3.48M ﹤0.01% 1544
2019
Q2
$3.64M Sell
23,769
-14,526
-38% -$2.22M 0.01% 875
2019
Q1
$6.14M Buy
38,295
+36,758
+2,392% +$5.7M 0.02% 721
2018
Q4
$237K Sell
1,537
-301
-16% -$46.9K ﹤0.01% 1535
2018
Q3
$276K Sell
1,838
-367
-17% -$52.1K ﹤0.01% 1564
2018
Q2
$298K Sell
2,205
-287
-12% -$35.4K ﹤0.01% 1483
2018
Q1
$332K Sell
2,492
-854
-26% -$115K ﹤0.01% 1453
2017
Q4
$498K Sell
3,346
-338
-9% -$46K ﹤0.01% 1380
2017
Q3
$486K Buy
3,684
+2,527
+218% +$340K ﹤0.01% 1378
2017
Q2
$154K Sell
1,157
-1,811
-61% -$244K ﹤0.01% 1559
2017
Q1
$401K Buy
2,968
+64
+2% +$8.29K ﹤0.01% 1383
2016
Q4
$349K Sell
2,904
-511
-15% -$60.3K ﹤0.01% 1404
2016
Q3
$428K Buy
3,415
+81
+2% +$10.6K ﹤0.01% 1327
2016
Q2
$462K Sell
3,334
-135
-4% -$17.5K ﹤0.01% 1293
2016
Q1
$437K Buy
3,469
+278
+9% +$35.3K ﹤0.01% 1315
2015
Q4
$405K Sell
3,191
-173
-5% -$21.5K ﹤0.01% 1349
2015
Q3
$389K Sell
3,364
-148
-4% -$16.6K ﹤0.01% 1354
2015
Q2
$365K Sell
3,512
-153
-4% -$16.5K ﹤0.01% 1399
2015
Q1
$405K Sell
3,665
-972
-21% -$106K ﹤0.01% 1415
2014
Q4
$483K Sell
4,637
-296
-6% -$29.6K ﹤0.01% 1364
2014
Q3
$474K Sell
4,933
-44
-0.9% -$3.98K ﹤0.01% 1367
2014
Q2
$455K Sell
4,977
-2,841
-36% -$254K ﹤0.01% 1377
2014
Q1
$688K Buy
7,818
+3,893
+99% +$342K ﹤0.01% 1261
2013
Q4
$364K Sell
3,925
-1,949
-33% -$176K ﹤0.01% 1390
2013
Q3
$480K Buy
5,874
+1,782
+44% +$150K ﹤0.01% 1314
2013
Q2
$340K Buy
+4,092
New +$352K ﹤0.01% 1374

Other funds holding CLX

Federated Hermes's CLX Position: Q1 2026 in Review

Federated Hermes increased its Clorox (CLX) stake by 23% in Q1 2026, buying an estimated $276K and bringing the position to 13,152 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1044.

Federated Hermes first reported a position in CLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $313M in Q4 2022. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Federated Hermes held 13,152 shares of Clorox worth $1.36M as of Q1 2026.
  • Federated Hermes bought 2,431 Clorox shares in Q1 2026, an estimated $276K.
  • Clorox made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1044 holding.
  • Federated Hermes first reported a position in Clorox in Q2 2013 and has held it in 52 quarters since.
  • Federated Hermes's Clorox position peaked at $313M in Q4 2022.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.